You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

selumetinib

Showing 26 - 50 of 59
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Lung Cancer, Melanoma, Head and Neck Carcinoma Trial in United States (Selumetinib, MEDI4736, Tremelimumab)

Completed
  • Lung Cancer
  • +7 more
  • Selumetinib
  • +2 more
  • Chicago, Illinois
  • +5 more
Nov 15, 2019

Muscle Invasive Bladder Cancer Trial in Worldwide (AZD4547, MEDI4736, Olaparib)

Active, not recruiting
  • Muscle Invasive Bladder Cancer
  • Los Angeles, California
  • +26 more
Oct 17, 2022

Metastatic Breast Cancer Trial in France (AZD2014, AZD4547, AZD5363)

Active, not recruiting
  • Metastatic Breast Cancer
  • Angers, France
  • +24 more
Mar 8, 2022

NSCLC Metastatic Trial in France (AZD2014, AZD4547, AZD5363)

Active, not recruiting
  • Non-small Cell Lung Cancer Metastatic
  • Avignon, France
  • +36 more
Jul 29, 2022

NSCLC Trial in Worldwide (Osimertinib, Savolitinib, Gefitinib)

Recruiting
  • Non-Small Cell Lung Cancer
  • Duarte, California
  • +52 more
Jan 19, 2023

NSCLC, Carcinoma, Squamous Cell, Adenocarcinoma Trial in United Kingdom (AZD4547, Vistusertib, Palbociclib)

Active, not recruiting
  • Non-Small Cell Lung Cancer
  • +2 more
  • Aberdeen, United Kingdom
  • +24 more
Nov 2, 2021

Differentiated Thyroid Cancer Trial in Worldwide (Selumetinib, Placebo, Radioactive Iodine Therapy)

Terminated
Has Results
  • Differentiated Thyroid Cancer
  • Selumetinib
  • +2 more
  • Birmingham, Alabama
  • +44 more
Aug 27, 2019

Colorectal Tumors, Gastrointestinal Tumors, Pancreatic Tumors Trial in Nijmegen, Amsterdam (Afatinib, Selumetinib, Docetaxel)

Unknown status
  • Colorectal Neoplasms
  • +3 more
  • Nijmegen, Gelderland, Netherlands
  • +1 more
Aug 24, 2018

NSCLC (NSCLC) Trial in Tainan, Taipei (selumetinib)

Completed
  • Non-small Cell Lung Cancer (NSCLC)
  • selumetinib
  • Tainan, Taiwan
  • +2 more
Jul 9, 2018

Endometrial Adenocarcinoma, Endometrial Adenosquamous Carcinoma, Endometrial Clear Cell Adenocarcinoma Trial in United States

Completed
Has Results
  • Endometrial Adenocarcinoma
  • +3 more
  • Diagnostic Laboratory Biomarker Analysis
  • Selumetinib
  • Los Angeles, California
  • +71 more
Jul 19, 2019

Breast Cancer Trial in Belgium, Switzerland (fulvestrant, selumetinib)

Completed
  • Breast Cancer
  • Ghent, Belgium
  • +16 more
May 13, 2019

Malignant Tumor of Respiratory and Intrathoracic Organ Carcinoma, Advanced Lung Cancer, Recurrent Nonsmall Cell Lung Cancer

Withdrawn
  • Malignant Neoplasm of Respiratory and Intrathoracic Organ Carcinoma
  • +2 more
  • Selumetinib
  • +2 more
  • (no location specified)
Mar 14, 2018

Locally Advanced or Metastatic NSCL Cancer Stage IIIB IV Trial in United Kingdom (selumetinib, gemcitabine, cisplatin)

Completed
Has Results
  • Locally Advanced or Metastatic NSCL Cancer Stage IIIB IV
  • selumetinib
  • +4 more
  • Glasgow, United Kingdom
  • +3 more
Mar 12, 2018

Recurrent Thyroid Gland Carcinoma, Stage I Thyroid Gland Papillary Carcinoma, Stage II Thyroid Gland Papillary Carcinoma Trial

Completed
Has Results
  • Recurrent Thyroid Gland Carcinoma
  • +4 more
  • Laboratory Biomarker Analysis
  • Selumetinib
  • Tampa, Florida
  • +5 more
Dec 2, 2016

Iris Melanoma, Medium/Large Size Posterior Uveal Melanoma, Ocular Melanoma With Extraocular Extension Trial in Canada, United

Completed
Has Results
  • Iris Melanoma
  • +5 more
  • Aurora, Colorado
  • +32 more
Jun 26, 2017

Inoperable Locally Advanced or Metastatic Biliary Tract Cancer Trial in Kashiwa Shi, Chuo Ku (Cisplatin, Gemcitabine,

Terminated
Has Results
  • Inoperable Locally Advanced or Metastatic Biliary Tract Cancer
  • Kashiwa Shi, Chiba, Japan
  • +1 more
May 5, 2016

Biliary Tract Tumors, Cholangiocarcinoma, Gallbladder Tumors Trial in London, Manchester (selumetinib, gemcitabine, cisplatin)

Completed
  • Biliary Tract Neoplasms
  • +2 more
  • selumetinib
  • +2 more
  • London, United Kingdom
  • +2 more
May 11, 2016

Liver and Intrahepatic Biliary Tract Cancer, Recurrent Extrahepatic Bile Duct Cancer, Unresectable Extrahepatic Bile Duct Cancer

Completed
Has Results
  • Liver and Intrahepatic Biliary Tract Cancer
  • +2 more
  • selumetinib
  • laboratory biomarker analysis
  • Tampa, Florida
  • +6 more
Mar 22, 2016

Adult Solid Tumor Trial in Baltimore (biological, other, drug)

Completed
  • Adult Solid Neoplasm
  • Cixutumumab
  • +3 more
  • Baltimore, Maryland
    Johns Hopkins University/Sidney Kimmel Cancer Center
Jan 22, 2016

Adult Solid Tumor Trial in Boston, Charlestown, New York (Selumetinib)

Completed
Has Results
  • Adult Solid Neoplasm
  • Selumetinib
  • Boston, Massachusetts
  • +4 more
Dec 10, 2015

Solid Tumours Trial in Overland Park (Selumetinib, Moxifloxacin, selumetinib )

Completed
Has Results
  • Solid Tumours
  • Selumetinib
  • +2 more
  • Overland Park, Kansas
    Research Site
Oct 7, 2015

Recurrent Adult Diffuse Large Cell Lymphoma Trial in United States (Laboratory Biomarker Analysis, Selumetinib)

Terminated
Has Results
  • Recurrent Adult Diffuse Large Cell Lymphoma
  • Laboratory Biomarker Analysis
  • Selumetinib
  • Chicago, Illinois
  • +15 more
Jan 4, 2016

Solid Tumours Trial in Overland Park (selumetinib, itraconazole, fluconazole)

Completed
  • Solid Tumours
  • selumetinib
  • +2 more
  • Overland Park, Kansas
    Research Site
Jun 29, 2015

Recurrent Adult Soft Tissue Sarcoma, Stage III Adult Soft Tissue Sarcoma, Stage IV Adult Soft Tissue Sarcoma Trial in United

Completed
Has Results
  • Recurrent Adult Soft Tissue Sarcoma
  • +2 more
  • Laboratory Biomarker Analysis
  • +2 more
  • Beverly Hills, California
  • +7 more
Sep 4, 2015

Solid Tumours Trial in Orlando (selumetinib)

Completed
  • Solid Tumours
  • selumetinib
  • Orlando, Florida
    Research Site
Jun 29, 2015